These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 16174670

  • 1. The effects of stereotype threat on cognitive function in ecstasy users.
    Cole JC, Michailidou K, Jerome L, Sumnall HR.
    J Psychopharmacol; 2006 Jul; 20(4):518-25. PubMed ID: 16174670
    [Abstract] [Full Text] [Related]

  • 2. Ecstasy use and higher-level cognitive functions: weak effects of ecstasy after control for potential confounds.
    Bedi G, Redman J.
    Psychol Med; 2008 Sep; 38(9):1319-30. PubMed ID: 18226286
    [Abstract] [Full Text] [Related]

  • 3. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
    de Sola Llopis S, Miguelez-Pan M, Peña-Casanova J, Poudevida S, Farré M, Pacifici R, Böhm P, Abanades S, Verdejo García A, Langohr K, Zuccaro P, de la Torre R.
    J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
    [Abstract] [Full Text] [Related]

  • 4. Everyday memory deficits in ecstasy-polydrug users.
    Montgomery C, Fisk JE.
    J Psychopharmacol; 2007 Sep; 21(7):709-17. PubMed ID: 17606476
    [Abstract] [Full Text] [Related]

  • 5. Electrophysiological indices of altered working memory processes in long-term ecstasy users.
    Nulsen C, Fox A, Hammond G.
    Hum Psychopharmacol; 2011 Oct; 26(7):488-97. PubMed ID: 21953632
    [Abstract] [Full Text] [Related]

  • 6. Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users.
    Fox HC, McLean A, Turner JJ, Parrott AC, Rogers R, Sahakian BJ.
    Psychopharmacology (Berl); 2002 Jul; 162(2):203-14. PubMed ID: 12110998
    [Abstract] [Full Text] [Related]

  • 7. Apparent transient effects of recent "ecstasy" use on cognitive performance and extrapyramidal signs in human subjects.
    Smith RM, Tivarus M, Campbell HL, Hillier A, Beversdorf DQ.
    Cogn Behav Neurol; 2006 Sep; 19(3):157-64. PubMed ID: 16957494
    [Abstract] [Full Text] [Related]

  • 8. Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users.
    Gouzoulis-Mayfrank E, Thimm B, Rezk M, Hensen G, Daumann J.
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):819-27. PubMed ID: 12921915
    [Abstract] [Full Text] [Related]

  • 9. Self reported sleep quality and cognitive performance in ecstasy users.
    Montgomery C, Fisk JE, Wareing M, Murphy P.
    Hum Psychopharmacol; 2007 Dec; 22(8):537-48. PubMed ID: 17960556
    [Abstract] [Full Text] [Related]

  • 10. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?
    Morgan MJ, McFie L, Fleetwood H, Robinson JA.
    Psychopharmacology (Berl); 2002 Jan; 159(3):294-303. PubMed ID: 11862362
    [Abstract] [Full Text] [Related]

  • 11. Ecstasy (MDMA) exposure and neuropsychological functioning: a polydrug perspective.
    Medina KL, Shear PK, Corcoran K.
    J Int Neuropsychol Soc; 2005 Oct; 11(6):753-65. PubMed ID: 16248911
    [Abstract] [Full Text] [Related]

  • 12. Information processing speed in ecstasy (MDMA) users.
    Wareing M, Fisk JE, Montgomery C, Murphy PN, Chandler MD.
    Hum Psychopharmacol; 2007 Mar; 22(2):81-8. PubMed ID: 17295197
    [Abstract] [Full Text] [Related]

  • 13. Ecstasy (MDMA) and memory function: a meta-analytic update.
    Laws KR, Kokkalis J.
    Hum Psychopharmacol; 2007 Aug; 22(6):381-8. PubMed ID: 17621368
    [Abstract] [Full Text] [Related]

  • 14. Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: evidence from an 18-month longitudinal functional magnetic resonance imaging study.
    Daumann J, Fischermann T, Heekeren K, Thron A, Gouzoulis-Mayfrank E.
    Biol Psychiatry; 2004 Sep 01; 56(5):349-55. PubMed ID: 15336517
    [Abstract] [Full Text] [Related]

  • 15. Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users.
    Schilt T, de Win MM, Jager G, Koeter MW, Ramsey NF, Schmand B, van den Brink W.
    Psychol Med; 2008 Sep 01; 38(9):1309-17. PubMed ID: 17988417
    [Abstract] [Full Text] [Related]

  • 16. Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol.
    Indlekofer F, Piechatzek M, Daamen M, Glasmacher C, Lieb R, Pfister H, Tucha O, Lange KW, Wittchen HU, Schütz CG.
    J Psychopharmacol; 2009 Jul 01; 23(5):495-509. PubMed ID: 18635709
    [Abstract] [Full Text] [Related]

  • 17. Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug.
    Fox HC, Parrott AC, Turner JJ.
    J Psychopharmacol; 2001 Dec 01; 15(4):273-81. PubMed ID: 11769821
    [Abstract] [Full Text] [Related]

  • 18. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R, Zapletalova P, Petersen K, Buchert R, Andresen B, Wartberg L, Nebeling B, Schmoldt A.
    J Psychopharmacol; 2006 Mar 01; 20(2):211-25. PubMed ID: 16510479
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.